<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82362">
  <stage>Registered</stage>
  <submitdate>19/10/2007</submitdate>
  <approvaldate>22/10/2007</approvaldate>
  <actrnumber>ACTRN12607000540415</actrnumber>
  <trial_identification>
    <studytitle>Comparison of fasting glucose and oral glucose tolerance testing to screen for diabetes mellitus in subjects on long-term glucocorticoid therapy</studytitle>
    <scientifictitle>Comparison of fasting glucose and oral glucose tolerance testing to screen for diabetes mellitus in subjects on long-term glucocorticoid therapy</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Risk of diabetes in subjects receiving long-term glucocorticoid therapy</healthcondition>
    <conditioncode>
      <conditioncode1>Metabolic and Endocrine</conditioncode1>
      <conditioncode2>Diabetes</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Oral glucose tolerance test: This involves a blood test to measure plasma glucose fasting and 2 hours after a 75 g glucose drink. The test takes two hours.</interventions>
    <comparator>Subjects with rheumatologic disease not on glucocorticoids</comparator>
    <control>Historical</control>
    <interventioncode>Diagnosis / Prognosis</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Sensitivity of fasting glucose to determine diabetes</outcome>
      <timepoint>At the end of the 12 month study period.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Prevalence of diabetes</outcome>
      <timepoint>At the end of the 12 month study period.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Long-term glucocorticoid therapy (&gt; 6 months)</inclusivecriteria>
    <inclusiveminage>30</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>-2147483648</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Type 1 diabetes mellitus
Active inflammatory disease (defined as clinical evidence of active synovitis, elevated C-reactive protein (CRP) or recent intensification of immunosuppressive therapy)
Significant hepatic (AST or ALT &gt; 3 times upper limit of normal) or renal (serum creatinine &gt; 200Âµmol/L) dysfunction</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs>Screening</purposeobs>
    <duration>Cross-sectional</duration>
    <selection>Case control</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>22/10/2007</anticipatedstartdate>
    <actualstartdate>22/10/2007</actualstartdate>
    <anticipatedenddate />
    <actualenddate>29/04/2011</actualenddate>
    <samplesize>150</samplesize>
    <actualsamplesize>118</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Repatriation General Hospital</primarysponsorname>
    <primarysponsoraddress>Daw Rd
Daw Park 5041 SA</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Foundation Daw Park</fundingname>
      <fundingaddress>Repatriation General Hospital
Daw Rd
Daw Park 5041 SA</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The primary purpose of this study is to determine the prevalence of diabetes in subjects on long-term glucocorticoid (steroid) therapy and the best way to diagnose diabetes in this patient group.</summary>
    <trialwebsite />
    <publication>Burt MG, Willenberg VM, Petersons CJ, Smith MD, Ahern MJ, Stranks SN. Screening for diabetes in patients with inflammatory rheumatologic disease administered long-term prednisolone: A cross-sectional study. Rheumatology 2012;51:1112-1119</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Repatriation General Hospital</ethicname>
      <ethicaddress>Daw Rd
Daw Park 5041 SA</ethicaddress>
      <ethicapprovaldate>23/07/2007</ethicapprovaldate>
      <hrec>RGH 36/07</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>A/Prof</title>
      <name>Dr Morton Burt</name>
      <address>Repatriation General Hospital
Daw Rd
Daw Park 5041 SA</address>
      <phone>08 82967666</phone>
      <fax />
      <email>morton.burt@rgh.sa.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Dr Morton Burt</name>
      <address>Repatriation General Hospital
Daw Rd
Daw Park 5041 SA</address>
      <phone>08 82967666</phone>
      <fax />
      <email>morton.burt@rgh.sa.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Morton Burt</name>
      <address>Repatriation General Hospital
Daw Rd
Daw Park 5041 SA</address>
      <phone>08 82967666</phone>
      <fax />
      <email>morton.burt@rgh.sa.gov.au</email>
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Morton Burt</name>
      <address>Southern Adelaide Diabetes and Endocrine Services
Repatriation General Hospital
Daws Rd, Daw Park SA 5041</address>
      <phone>61882751094</phone>
      <fax />
      <email>morton.burt@sa.gov.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>